News and Analysis

Apnimed will apply the IPO proceeds toward the regulatory process and launch plans of Oxnimbi, a once-nightly pill developed for obstructive sleep apnea. This drug

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. on Sunday said President Trump “certainly” wants him to investigate perceived links between autism and

CALIFORNIA, USA, August 2nd, 2026, CyberNewswire AccuKnox, a leading Zero Trust Security platform, today announced that SabPaisa, an RBI-authorised digital payments company, has selected its

The drug-resistant and deadly fungus Candida auris has proven hard to stamp out in 2026. Despite efforts to contain its spread, the fungus is once